05-Aug-2020 | Zion Market Research
As per Zion Market Research, the cardiac resynchronization therapy market is predicted to cross $5.55 billion by 2026 at a CAGR of 4.8% from $4.3 billion in 2019. The development of the market is primarily boosted by the rising occurrence of target diseases (majorly owing to the increasing elderly population). Increasing support and investments together with technical enhancements are also acting as a catalyst for the development of the global market.
Major players in the global cardiac resynchronization therapy market are Abbott, Medtronic, MicroPort Scientific Corporation, Boston Scientific Corporation, Medico S.p.A., and BIOTRONIK.
CRT-Ds Segment Added Up For The Biggest Share Of The Cardiac Resynchronization Therapy Market
Based on product type, the global cardiac resynchronization therapy market is divided into cardiac resynchronization therapy Pacemakers (CRT-Ps) and cardiac resynchronization therapy Defibrillators (CRT-Ds). The CRT-Ds section added for the biggest share of the market in 2019. This is primarily credited to the rising recognition of CRT-Ds as compared to pacemakers and the roll out of technically enhanced machines. In addition to this, the development in this market section is majorly boosted by the rising occurrence of target diseases.
Hospitals & Cardiac Centers Added Up The Biggest Share Of The Global Market
Based on end user, the market is divided into ambulatory surgery centers and hospitals & cardiac centers. Hospitals & cardiac centers added up for the biggest share of the global cardiac resynchronization therapy market in 2019. The rising occurrence of CVD, increasing number of surgical operations conducted, rising number of intensive care & critical care units, and favorable reimbursement scenario are some of the major reasons boosting the development of the this segment.
Asia Pacific Predicted To Develop At Rapid Speed During The Years To Come
Asia Pacific area is expected to clock the max rate of growth during the forecast period in the global market. The increasing elderly population in China, encouraging reimbursement cases in Japan, enhancing healthcare infrastructure, increasing cases of CVDs, increasing disposable revenue levels in India, and increasing middle-class population are some of the major factors boosting the development of the Asia Pacific cardiac resynchronization therapy market.
Browse the full “Cardiac Resynchronization Therapy Market - by End User (Ambulatory Surgery Centers and Hospitals & Cardiac Centers), by Product Type (Cardiac Resynchronization Therapy Pacemaker and Cardiac Resynchronization Therapy Defibrillator), and by Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026.” Report at https://www.zionmarketresearch.com/report/cardiac-resynchronization-therapy-market
The global cardiac resynchronization therapy market is segmented as follows:
By Product Type
By End User
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651